Xeris Biopharma Holdings Q1 EPS $(0.14) Misses $(0.12) Estimate, Sales $40.64M Miss $41.81M Estimate
Xeris Biopharma Holdings Q1 EPS $(0.14) Misses $(0.12) Estimate, Sales $40.64M Miss $41.81M Estimate
Xeris Biopharma Holdings第一季度每股收益美元（0.14）未达到预期（0.12）美元，销售额为4,064万美元，低于4181万美元的预期
Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 16.67 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $40.64 million which missed the analyst consensus estimate of $41.81 million by 2.80 percent. This is a 22.42 percent increase over sales of $33.20 million the same period last year.
Xeris Biopharma Holdings（纳斯达克股票代码：XERS）公布的季度亏损为每股0.14美元，比分析师普遍预期的0.12美元（0.12美元）低16.67％。这比去年同期每股亏损0.12美元（0.12美元）下降了16.67％。该公司公布的季度销售额为4,064万美元，比分析师普遍预期的4181万美元低2.80％。这比去年同期的3320万美元销售额增长了22.42％。